Fosfomycin
Treatment for Urinary Tract Infections And Interstitial Nephritis
Typical Dosage: 3g single dose
Effectiveness
87%
Safety Score
70%
Clinical Trials
150
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
3g single dose
Time to Effect
1-2 days
Treatment Duration
single dose
Evidence Quality
MODERATENumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$45
Monitoring:$600
Side Effect Mgmt:$2
Total Annual:$647
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
Outcome-Based Costs
Cost per Responder
$55
Cost per Remission
$60
Prescription Access Economics
Annual Societal Loss per Patient
$160
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$15/year
Prior auth, claims
Rx Price
$45/year
Potential OTC Price
$15/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
MODERATEFosfomycin Outcomes
for Urinary Tract Infections And Interstitial Nephritis
Efficacy Outcomes
Overall Effectiveness
+87%
Response Rate
+85%
Remission Rate
+78%
Common Side Effects
Diarrhea
+7%
Nausea
+3%
Headache
+2%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov